161 related articles for article (PubMed ID: 7802670)
1. Destruxin B, a specific and readily reversible inhibitor of vacuolar-type H(+)-translocating ATPase.
Muroi M; Shiragami N; Takatsuki A
Biochem Biophys Res Commun; 1994 Dec; 205(2):1358-65. PubMed ID: 7802670
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of vacuolar-type H(+)-ATPase suppresses proliferation of cultured cells.
Manabe T; Yoshimori T; Henomatsu N; Tashiro Y
J Cell Physiol; 1993 Dec; 157(3):445-52. PubMed ID: 8253855
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase.
Gagliardi S; Gatti PA; Belfiore P; Zocchetti A; Clarke GD; Farina C
J Med Chem; 1998 May; 41(11):1883-93. PubMed ID: 9599238
[TBL] [Abstract][Full Text] [Related]
4. Relative roles of Na+/H+ exchange and vacuolar-type H+ ATPases in regulating cytoplasmic pH and function in murine peritoneal macrophages.
Swallow CJ; Grinstein S; Sudsbury RA; Rotstein OD
J Cell Physiol; 1993 Dec; 157(3):453-60. PubMed ID: 8253856
[TBL] [Abstract][Full Text] [Related]
5. Specific inhibitors of vacuolar type H(+)-ATPases induce apoptotic cell death.
Nishihara T; Akifusa S; Koseki T; Kato S; Muro M; Hanada N
Biochem Biophys Res Commun; 1995 Jul; 212(1):255-62. PubMed ID: 7612014
[TBL] [Abstract][Full Text] [Related]
6. A new destruxin as inhibitor of vacuolar-type H+-ATPase of Saccharomyces cerevisiae.
Vázquez MJ; Albarrán MI; Espada A; Rivera-Sagredo A; Díez E; Hueso-Rodríguez JA
Chem Biodivers; 2005 Jan; 2(1):123-30. PubMed ID: 17191925
[TBL] [Abstract][Full Text] [Related]
7. Immunological detection of a vacuolar-type H(+)-ATPase in vanadocytes of the ascidian Ascidia sydneiensis samea.
Uyama T; Moriyama Y; Futai M; Michibata H
J Exp Zool; 1994 Oct; 270(2):148-54. PubMed ID: 7964552
[TBL] [Abstract][Full Text] [Related]
8. Effects of efrapeptin and destruxin, metabolites of entomogenous fungi, on the hydrolytic activity of a vacuolar type ATPase identified on the brush border membrane vesicles of Galleria mellonella midgut and on plant membrane bound hydrolytic enzymes.
Bandani AR; Amiri B; Butt TM; Gordon-Weeks R
Biochim Biophys Acta; 2001 Feb; 1510(1-2):367-77. PubMed ID: 11342173
[TBL] [Abstract][Full Text] [Related]
9. Bafilomycin A1 inhibits lysosomal, phagosomal, and plasma membrane H(+)-ATPase and induces lysosomal enzyme secretion in macrophages.
Tapper H; Sundler R
J Cell Physiol; 1995 Apr; 163(1):137-44. PubMed ID: 7896890
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
Mattsson JP; Väänänen K; Wallmark B; Lorentzon P
Biochim Biophys Acta; 1991 Jun; 1065(2):261-8. PubMed ID: 1647821
[TBL] [Abstract][Full Text] [Related]
11. Yersinia pseudotuberculosis blocks the phagosomal acidification of B10.A mouse macrophages through the inhibition of vacuolar H(+)-ATPase activity.
Tsukano H; Kura F; Inoue S; Sato S; Izumiya H; Yasuda T; Watanabe H
Microb Pathog; 1999 Oct; 27(4):253-63. PubMed ID: 10502466
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-atpases.
Boyd MR; Farina C; Belfiore P; Gagliardi S; Kim JW; Hayakawa Y; Beutler JA; McKee TC; Bowman BJ; Bowman EJ
J Pharmacol Exp Ther; 2001 Apr; 297(1):114-20. PubMed ID: 11259534
[TBL] [Abstract][Full Text] [Related]
13. Involvement of V-ATPases in the digestion of soft connective tissue collagen.
Creemers LB; Jansen ID; Hoeben KA; Beertsen W; Everts V
Biochem Biophys Res Commun; 1998 Oct; 251(2):429-36. PubMed ID: 9792791
[TBL] [Abstract][Full Text] [Related]
14. [Bafilomycins and related compounds as vacuolar H(+)-ATPase inhibitors].
Moriyama Y; Futai M; Yoshimori T; Yamamoto A; Tashiro Y
Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):2000-11. PubMed ID: 8210440
[No Abstract] [Full Text] [Related]
15. Arrest of endosome acidification by bafilomycin A1 mimics insulin action on GLUT4 translocation in 3T3-L1 adipocytes.
Chinni SR; Shisheva A
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):599-606. PubMed ID: 10215598
[TBL] [Abstract][Full Text] [Related]
16. Patch clamp studies on V-type ATPase of vacuolar membrane of haploid Saccharomyces cerevisiae. Preparation and utilization of a giant cell containing a giant vacuole.
Yabe I; Horiuchi K; Nakahara K; Hiyama T; Yamanaka T; Wang PC; Toda K; Hirata A; Ohsumi Y; Hirata R; Anraku Y; Kusaka I
J Biol Chem; 1999 Dec; 274(49):34903-10. PubMed ID: 10574964
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of p53 and apoptosis induced by blockade of the vacuolar proton ATPase in cardiomyocytes.
Long X; Crow MT; Sollott SJ; O'Neill L; Menees DS; de Lourdes Hipolito M; Boluyt MO; Asai T; Lakatta EG
J Clin Invest; 1998 Mar; 101(6):1453-61. PubMed ID: 9502788
[TBL] [Abstract][Full Text] [Related]
18. Regulation and reversibility of vacuolar H(+)-ATPase.
Hirata T; Nakamura N; Omote H; Wada Y; Futai M
J Biol Chem; 2000 Jan; 275(1):386-9. PubMed ID: 10617629
[TBL] [Abstract][Full Text] [Related]
19. Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity.
Kataoka T; Takaku K; Magae J; Shinohara N; Takayama H; Kondo S; Nagai K
J Immunol; 1994 Nov; 153(9):3938-47. PubMed ID: 7930604
[TBL] [Abstract][Full Text] [Related]
20. Interaction of inhibitors of the vacuolar H(+)-ATPase with the transmembrane Vo-sector.
Páli T; Whyteside G; Dixon N; Kee TP; Ball S; Harrison MA; Findlay JB; Finbow ME; Marsh D
Biochemistry; 2004 Sep; 43(38):12297-305. PubMed ID: 15379568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
